Product Program year 2025 Source: CMS Open Payments

Nalocet

Drug Pain

NDC 72245-193-10

Open in the dashboard

General payments

$404,479

17,755 payments

Research payments

$0

0 payments

Through program year 2025, $404,479 in general payments and $0 in research payments were reported against Nalocet (Pain).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $120,601 5,557
2024 General $118,175 5,749
2023 General $92,793 4,938
2022 General $59,975 1,026
2019 General $12,935 485

Breakdown

Who paid General payments · program years 2019–2025
  1. Forte Bio-Pharma LLC $404,479 17,755 payments
Top recipients General payments · program year 2025
  1. Trishaben Patel Interventional Pain Medicine · Anaheim, CA $1,302 1% · 77 payments
  2. Michael Dana Physician Assistant · Marion, NC $1,288 1% · 28 payments
  3. Shinto Koshy Physical Medicine & Rehabilitation · Placentia, CA $1,175 <1% · 54 payments
  4. Gordon Iwasaki Physician Assistant, Medical · Murrieta, CA $1,007 <1% · 48 payments
  5. Russell Feit Pain Medicine · Palm Beach Gardens, FL $909 <1% · 29 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nurse Practitioner, Family Nurse Practitioner $21,852 18% · 186 practitioners
  2. Physician Assistant $21,498 18% · 169 practitioners
  3. Interventional Pain Medicine Pain Medicine $13,683 11% · 112 practitioners
  4. Pain Medicine Anesthesiology $9,705 8% · 115 practitioners
  5. Nurse Practitioner $7,922 7% · 73 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $21,404 18% · 179 recipients
  2. South Carolina $18,419 15% · 135 recipients
  3. California $17,376 14% · 76 recipients
  4. Nevada $10,270 9% · 92 recipients
  5. Texas $10,083 8% · 66 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

91

Prescriptions dispensed, refills included

Drug cost

$152,926

Paid at the pharmacy, in all

Prescribers

7

With 11 or more claims of it

Medicare Part D drugs matched to NALOCET, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Nalocet Oxycodone Hcl/Acetaminophen Same name 7 91 $152,926

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 7 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Don McCormick Physical Medicine and Rehabilitation AL 16 $24,812 $14
Eric Chung Physician Assistant CA 15 $31,260 $27
Jonathan Sorelle Hand Surgery NV 15 $12,717 None on record
Austin Replogle Physician Assistant NY 12 $9,259 $45
Neil Kirschbaum Interventional Pain Management FL 11 $36,578 $21

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See all 7 in the dashboard with a free account
17,755 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record